SK87299A3 - Method for the preparation of omeprazole and pharmaceutical composition containing the same - Google Patents

Method for the preparation of omeprazole and pharmaceutical composition containing the same Download PDF

Info

Publication number
SK87299A3
SK87299A3 SK872-99A SK87299A SK87299A3 SK 87299 A3 SK87299 A3 SK 87299A3 SK 87299 A SK87299 A SK 87299A SK 87299 A3 SK87299 A3 SK 87299A3
Authority
SK
Slovakia
Prior art keywords
omeprazole
methoxy
process according
prepared
preparation
Prior art date
Application number
SK872-99A
Other languages
English (en)
Slovak (sk)
Inventor
Hanna Cotton
Magnus Larsson
Anders Mattson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK87299A3 publication Critical patent/SK87299A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
SK872-99A 1997-11-14 1998-11-03 Method for the preparation of omeprazole and pharmaceutical composition containing the same SK87299A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704183A SE9704183D0 (sv) 1997-11-14 1997-11-14 New process
PCT/SE1998/001984 WO1999025711A1 (en) 1997-11-14 1998-11-03 New process

Publications (1)

Publication Number Publication Date
SK87299A3 true SK87299A3 (en) 2000-02-14

Family

ID=20408989

Family Applications (1)

Application Number Title Priority Date Filing Date
SK872-99A SK87299A3 (en) 1997-11-14 1998-11-03 Method for the preparation of omeprazole and pharmaceutical composition containing the same

Country Status (35)

Country Link
US (1) US6303788B1 (no)
EP (1) EP0964859A1 (no)
JP (1) JP2001508466A (no)
KR (1) KR20000070069A (no)
CN (1) CN1145624C (no)
AR (1) AR013740A1 (no)
AU (1) AU750743B2 (no)
BR (1) BR9806871A (no)
CA (1) CA2276753A1 (no)
DE (1) DE964859T1 (no)
DZ (1) DZ2641A1 (no)
EE (1) EE04154B1 (no)
ES (1) ES2138950T1 (no)
GR (1) GR990300046T1 (no)
HR (1) HRP990218A2 (no)
HU (1) HUP0003737A3 (no)
ID (1) ID21999A (no)
IL (1) IL130647A0 (no)
IN (1) IN190801B (no)
IS (1) IS5106A (no)
MA (1) MA26564A1 (no)
MY (1) MY118199A (no)
NO (1) NO318197B1 (no)
NZ (1) NZ336447A (no)
PL (1) PL334701A1 (no)
RU (1) RU2211218C2 (no)
SE (1) SE9704183D0 (no)
SK (1) SK87299A3 (no)
TN (1) TNSN98202A1 (no)
TR (1) TR199901643T1 (no)
TW (1) TW588046B (no)
UA (1) UA68342C2 (no)
WO (1) WO1999025711A1 (no)
YU (1) YU31199A (no)
ZA (1) ZA989999B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
JP2004524303A (ja) 2001-02-02 2004-08-12 テバ ファーマシューティカル インダストリーズ リミティド 置換された２−（２−ピリジルメチル）スルフィニル−１ｈ−ベンゾイミダゾール類の製造方法
SE0203092D0 (en) 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
PL1802584T3 (pl) * 2004-10-11 2010-03-31 Ranbaxy Laboratories Ltd Sposób wytwarzania podstawionych sulfotlenków
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
CN1810803B (zh) * 2006-02-17 2010-11-17 中国科学院上海有机化学研究所 高对映体选择性制备(s)-奥美拉唑的方法
CN101538264A (zh) * 2008-03-19 2009-09-23 中国科学院成都有机化学有限公司 手性亚砜类化合物的制备新方法
CN102603621B (zh) * 2012-02-07 2013-09-04 成都苑东药业有限公司 一种新型手性亚砜化合物和以该化合物制备埃索美拉唑钠的方法
CN106083819A (zh) * 2016-06-08 2016-11-09 扬子江药业集团有限公司 一种奥美拉唑的制备方法
ES2948511A1 (es) * 2021-09-08 2023-09-13 Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa Derivados de n-sulfonilureas y su uso terapeutico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE9002043D0 (sv) 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider

Also Published As

Publication number Publication date
NO993298D0 (no) 1999-07-02
BR9806871A (pt) 2000-04-18
AR013740A1 (es) 2001-01-10
IN190801B (no) 2003-08-23
TR199901643T1 (xx) 2000-01-21
UA68342C2 (en) 2004-08-16
TNSN98202A1 (fr) 2005-03-15
NO993298L (no) 1999-07-02
CA2276753A1 (en) 1999-05-27
ZA989999B (en) 1999-06-17
PL334701A1 (en) 2000-03-13
GR990300046T1 (en) 2000-07-31
SE9704183D0 (sv) 1997-11-14
DZ2641A1 (fr) 2003-03-15
IS5106A (is) 1999-07-02
WO1999025711A1 (en) 1999-05-27
CN1145624C (zh) 2004-04-14
MA26564A1 (fr) 2004-12-20
AU750743B2 (en) 2002-07-25
AU1058299A (en) 1999-06-07
HUP0003737A2 (hu) 2001-10-28
YU31199A (sh) 2002-06-19
NZ336447A (en) 2001-02-23
US6303788B1 (en) 2001-10-16
ID21999A (id) 1999-08-19
EE04154B1 (et) 2003-10-15
EE9900391A (et) 2000-04-17
CN1243512A (zh) 2000-02-02
HRP990218A2 (en) 2000-08-31
HUP0003737A3 (en) 2002-01-28
TW588046B (en) 2004-05-21
JP2001508466A (ja) 2001-06-26
DE964859T1 (de) 2000-05-04
ES2138950T1 (es) 2000-02-01
KR20000070069A (ko) 2000-11-25
NO318197B1 (no) 2005-02-14
MY118199A (en) 2004-09-30
IL130647A0 (en) 2000-06-01
RU2211218C2 (ru) 2003-08-27
EP0964859A1 (en) 1999-12-22

Similar Documents

Publication Publication Date Title
RU2157806C2 (ru) Способы синтеза замещенных сульфоксидов
CA2409044C (en) Improved recrystallization processes for obtaining anhydrous optically active lansoprazole
SK87299A3 (en) Method for the preparation of omeprazole and pharmaceutical composition containing the same
US7452998B2 (en) Process for preparing optically pure active compounds
MXPA03006904A (es) Procesos para la produccion de 2-(2-piridilmetil) sulfinil - 1h - bencimidazoles sustituidos.
CA2507889C (en) Process for preparing (s)-pantoprazole
US7064213B1 (en) Method for preparing 2- (2-pyridylmethylsulphinyl) benzimidazoles
CZ249699A3 (cs) Nový způsob zpracování
MXPA99006369A (en) New process
US20070225500A1 (en) Process for the Preparation of Pyridin-2-Ylmethylsulphinyl-1H-Benzimidazol Compounds
MXPA00008482A (en) Chemical process for the production of sulphinyl derivatives by oxidation of the corresponding co-derivatives with perborates
AU2002240242A1 (en) Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles